THQ · abrdn Healthcare Opportunities Fund · Fund Holdings
Market Cap
$794.77M
Shares
41.44M
Volume · Nov 12
98.47K
Avg daily vol (3M)
125.31K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Portfolio holdings reported by registered funds to the SEC on Form N-PORT — the individual securities a fund owns. Only mutual funds, ETFs and closed-end funds file N-PORT, so operating companies show no data.
abrdn Healthcare Opportunities Fund
Reported 2026-06-30Net Assets
$825,731,795
Total Assets
$1,054,124,193
Holdings
110
Filed
2026-08-28
| Holding | CUSIP | Balance | Units | Value | % Net Assets | Category | Country |
|---|---|---|---|---|---|---|---|
| UnitedHealth Group Inc | 91324P102 | 120,631 | NS | $50,137,863 | 6.07% | EC | US |
| VeraDermics Inc | 922967104 | 353,716 | NS | $43,485,845 | 5.27% | EC | US |
| Abbott Laboratories | 002824100 | 433,683 | NS | $39,352,395 | 4.77% | EC | US |
| Merck & Co Inc | 58933Y105 | 283,202 | NS | $36,391,457 | 4.41% | EC | US |
| Medtronic PLC | 000000000 | 449,937 | NS | $35,198,572 | 4.26% | EC | IE |
| Thermo Fisher Scientific Inc | 883556102 | 68,956 | NS | $34,571,780 | 4.19% | EC | US |
| VERADERMICS, INC. | 000000000 | 273,261 | NS | $33,594,707 | 4.07% | EP | US |
| Intuitive Surgical Inc | 46120E602 | 70,415 | NS | $28,002,637 | 3.39% | EC | US |
| CVS Health Corp | 126650100 | 263,513 | NS | $27,260,420 | 3.30% | EC | US |
| Danaher Corp | 235851102 | 139,737 | NS | $26,617,104 | 3.22% | EC | US |
| Oruka Therapeutics Inc | 687604108 | 250,767 | NS | $23,865,495 | 2.89% | EC | US |
| uniQure NV | 000000000 | 496,969 | NS | $22,890,392 | 2.77% | EC | NL |
| Humana Inc | 444859102 | 57,188 | NS | $22,716,217 | 2.75% | EC | US |
| Elevance Health Inc | 036752103 | 54,645 | NS | $21,132,861 | 2.56% | EC | US |
| BioCryst Pharmaceuticals Inc | 09058V103 | 2,088,571 | NS | $20,885,710 | 2.53% | EC | US |
| AbbVie Inc | 00287Y109 | 80,912 | NS | $20,360,696 | 2.47% | EC | US |
| Boston Scientific Corp | 101137107 | 465,063 | NS | $19,848,889 | 2.40% | EC | US |
| Sarepta Therapeutics Inc | 803607100 | 921,334 | NS | $16,556,372 | 2.01% | EC | US |
| NeoGenomics Inc | 64049M209 | 1,069,634 | NS | $15,605,960 | 1.89% | EC | US |
| Insulet Corp | 45784P101 | 101,696 | NS | $15,483,216 | 1.88% | EC | US |
| State Street Global Advisors | 857492706 | 15,337,270 | NS | $15,337,270 | 1.86% | STIV | US |
| Praxis Precision Medicines Inc | 74006W207 | 43,765 | NS | $14,652,084 | 1.77% | EC | US |
| ARS Pharmaceuticals Inc | 82835W108 | 1,805,535 | NS | $14,462,335 | 1.75% | EC | US |
| Abivax SA | 00370M103 | 104,341 | NS | $13,904,482 | 1.68% | EC | FR |
| Alignment Healthcare Inc | 01625V104 | 577,052 | NS | $13,739,608 | 1.66% | EC | US |
| Omega Healthcare Investors Inc | 681936100 | 278,033 | NS | $13,256,613 | 1.61% | EC | US |
| Welltower Inc | 95040Q104 | 57,915 | NS | $13,144,968 | 1.59% | EC | US |
| Vericel Corp | 92346J108 | 294,506 | NS | $13,102,572 | 1.59% | EC | US |
| Bristol-Myers Squibb Co | 110122108 | 221,600 | NS | $12,768,592 | 1.55% | EC | US |
| Molina Healthcare Inc | 60855R100 | 52,318 | NS | $11,965,127 | 1.45% | EC | US |
| GeneDx Holdings Corp | 81663L200 | 171,640 | NS | $11,783,086 | 1.43% | EC | US |
| Acadia Healthcare Co Inc | 00404A109 | 353,243 | NS | $10,431,266 | 1.26% | EC | US |
| Healthpeak Properties Inc | 42250P103 | 485,067 | NS | $10,380,434 | 1.26% | EC | US |
| ABBOTT LABORATORIES | 002824BG4 | 10,498,000 | PA | $10,245,539 | 1.24% | DBT | US |
| Charles River Laboratories International Inc | 159864107 | 44,454 | NS | $10,081,723 | 1.22% | EC | US |
| Ventas Inc | 92276F100 | 110,408 | NS | $9,804,230 | 1.19% | EC | US |
| Oculis Holding AG | 000000000 | 688,455 | NS | $9,548,871 | 1.16% | EC | CH |
| Zoetis Inc | 98978V103 | 131,249 | NS | $9,431,553 | 1.14% | EC | US |
| Sabra Health Care REIT Inc | 78573L106 | 482,214 | NS | $9,407,995 | 1.14% | EC | US |
| Biodesix Inc | 09075X207 | 395,315 | NS | $8,914,353 | 1.08% | EC | US |
| Stryker Corp | 863667101 | 27,571 | NS | $8,680,454 | 1.05% | EC | US |
| CIGNA GROUP/THE | 125523CD0 | 8,250,000 | PA | $8,658,099 | 1.05% | DBT | US |
| ICON PLC | 000000000 | 49,689 | NS | $8,631,476 | 1.05% | EC | IE |
| JOHNSON & JOHNSON | 478160BV5 | 10,130,000 | PA | $8,090,851 | 0.98% | DBT | US |
| PFIZER INC | 717081ET6 | 8,100,000 | PA | $7,911,454 | 0.96% | DBT | US |
| GE HealthCare Technologies Inc | 36266G107 | 121,807 | NS | $7,796,866 | 0.94% | EC | US |
| Waters Corp | 941848103 | 20,517 | NS | $7,694,696 | 0.93% | EC | US |
| McKesson Corp | 58155Q103 | 9,893 | NS | $7,475,151 | 0.91% | EC | US |
| Myriad Genetics Inc | 62855J104 | 1,308,933 | NS | $7,474,007 | 0.91% | EC | US |
| Disc Medicine Inc | 254604101 | 100,151 | NS | $7,325,044 | 0.89% | EC | US |
Showing 1–50 of 110 holdings